↓ Skip to main content

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial

Overview of attention for article published in Cardiovascular Diabetology, January 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
26 X users

Readers on

mendeley
173 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial
Published in
Cardiovascular Diabetology, January 2018
DOI 10.1186/s12933-017-0654-z
Pubmed ID
Authors

M. V. Karg, A. Bosch, D. Kannenkeril, K. Striepe, C. Ott, M. P. Schneider, F. Boemke-Zelch, P. Linz, A. M. Nagel, J. Titze, M. Uder, R. E. Schmieder

X Demographics

X Demographics

The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 173 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 173 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 17 10%
Researcher 17 10%
Student > Bachelor 17 10%
Student > Doctoral Student 15 9%
Student > Master 11 6%
Other 30 17%
Unknown 66 38%
Readers by discipline Count As %
Medicine and Dentistry 61 35%
Biochemistry, Genetics and Molecular Biology 10 6%
Nursing and Health Professions 7 4%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Engineering 3 2%
Other 10 6%
Unknown 76 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2022.
All research outputs
#2,258,359
of 25,481,734 outputs
Outputs from Cardiovascular Diabetology
#165
of 1,665 outputs
Outputs of similar age
#49,981
of 451,036 outputs
Outputs of similar age from Cardiovascular Diabetology
#3
of 21 outputs
Altmetric has tracked 25,481,734 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,665 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,036 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.